Previous work done by Pascual-Garcia et al. identified the IL-6 class cytokine Leukemia Inhibitor Factor (LIF) as a potential direct regulator of CXCL9 expression in human GBM preventing recruitment of CD8 + T cells and impairing anti-PD-1 therapy72. Here, CXCL9 is linked to glioblastoma.